查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
北美内皮功能障碍市场预测至 2028 年 - 区域分析 - 按原因、测试类型和最终用户
市场调查报告书
商品编码
1420203

北美内皮功能障碍市场预测至 2028 年 - 区域分析 - 按原因、测试类型和最终用户

North America Endothelial Dysfunction Market Forecast to 2028 - Regional Analysis - by Cause, Test Type, and End User
出版日期: | 出版商: The Insight Partners | 英文 115 Pages | 订单完成后即时交付

价格

北美内皮功能障碍市场预计将从2022年的9.5183亿美元成长到2028年的12.473亿美元。预计2022年至2028年CAGR为4.6%。

心血管疾病发生率的增加推动了北美内皮功能障碍市场

根据世界卫生组织 (WHO) 的数据，心血管疾病 (CVD) 是全球主要死亡原因之一，每年约有 3000 万人中风。 CVD包括脑血管疾病、冠状动脉心臟病、风湿性心臟病和冠状动脉疾病(CAD)。 CAD是所有心血管疾病中最常见的疾病，其特征是脂质和免疫细胞在冠状动脉内皮下间隙积聚或动脉粥状硬化。它涉及血管内皮的发炎反应。 CAD的特征是由于动脉粥状硬化导致冠状动脉管腔变窄、痉挛或阻塞而导致心肌缺血、缺氧或坏死。它已成为全世界死亡的主要原因。根据美国疾病管制与预防中心 (CDC) 的数据，美国有超过 6,000 万名女性 (44%) 患有某种形式的心臟病。心臟病是美国女性死亡的主要原因，可以影响任何年龄层的女性。 2021年，它造成了310,661名女性死亡，即近五分之一的女性死亡。

根据美国心臟协会的数据，美国几乎一半的成年人患有某种类型的心血管疾病。预计到 2035 年，将有超过 1.3 亿人（即美国人口的 45.1%）患有某种类型的心血管疾病。因此，内皮功能障碍导致的心血管疾病的高盛行率推动了市场的发展。

北美内皮功能障碍市场概述

北美内皮功能障碍市场以三个主要国家为基础进行分析：美国、加拿大和墨西哥。该地区的市场扩张可归因于心臟病发病率的增加和心臟病资讯学投资的增加。由于CAD负担日益增加、医疗基础设施完善以及为开发先进的内皮功能障碍药物和设备而开展的研发活动等因素，美国拥有北美最大的内皮功能障碍市场规模。

北美内皮功能障碍市场收入及 2028 年预测（百万美元）

北美内皮功能障碍市场细分

北美内皮功能障碍市场按原因、测试类型、最终用户和国家进行细分。

根据病因，北美内皮功能障碍市场分为高血压、高胆固醇血症、肥胖、糖尿病、白塞氏症等。 2022 年，高血压细分市场在北美内皮功能障碍市占率最大。

根据测试类型，北美内皮功能障碍市场分为侵入性测试和非侵入性测试。到2022 年，侵入性测试细分市场将占据较大的北美内皮功能障碍市场份额。非侵入性测试细分市场进一步细分为血流介导扩张、週边动脉张力测定(PAT)、静脉闭塞体积描记术、循环标记物等。

根据最终用户，北美内皮功能障碍市场可分为医院、诊断中心、诊所等。 2022 年，医院细分市场占据北美最大的内皮功能障碍市场。

根据国家/地区，北美内皮功能障碍市场分为美国、加拿大和墨西哥。 2022 年，美国主导北美内皮功能障碍市场。

ZOLL Medical Corp、劳伦斯伯克利国家实验室、Endothelix Inc、Perimed AB、SMART Medical Ltd、Everist Health Inc 和 Medizinische Messtechnik GmbH 是该地区内皮功能障碍市场的一些领先公司。

目录

第 1 章：简介

  • 研究范围
  • Insight Partners 研究报告指南
  • 市场区隔
    • 北美内皮功能障碍市场 - 按原因分类
    • 北美内皮功能障碍市场 - 按测试类型
    • 北美内皮功能障碍市场 - 按最终用户
    • 北美内皮功能障碍市场 - 按国家/地区

第 2 章：北美内皮功能障碍市场 - 要点

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：北美内皮功能障碍市场 - 市场格局

  • 概述
  • PEST分析
    • 北美 PEST 分析
  • 专家意见

第 5 章：北美内皮功能障碍市场 - 主要市场动态

  • 市场驱动因素
    • 心血管疾病发生率增加
    • 高胆固醇、糖尿病和肥胖症的发生率上升
  • 市场限制
    • 内皮功能障碍筛检技术的缺点
  • 市场机会
    • 新型生物标记和治疗策略的使用不断增加
  • 未来的趋势
    • 使用非侵入性方法评估内皮功能障碍
  • 影响分析

第 6 章：内皮功能障碍市场 - 北美分析

  • 北美内皮功能障碍市场收入预测与分析

第 7 章：北美内皮功能障碍市场分析 - 按原因

  • 概述
  • 北美内皮功能障碍市场，依原因划分，2022 年和 2028 年 (%)
  • 高血压
  • 糖尿病
  • 高胆固醇血症
  • 白塞氏症
  • 肥胖
  • 其他的

第 8 章：北美内皮功能障碍市场分析 - 按测试类型

  • 概述
  • 北美内皮功能障碍市场，按测试类型，2022 年和 2028 年 (%)
  • 侵入性测试
  • 非侵入性测试

第 9 章：北美内皮功能障碍市场分析 - 按最终用户

  • 概述
  • 北美内皮功能障碍市场，按最终用户划分，2022 年和 2028 年 (%)
  • 医院
  • 诊断中心
  • 诊所
  • 其他的

第 10 章：北美内皮功能障碍市场 - 收入和 2028 年预测 - 国家分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥

第 11 章：北美内皮功能障碍市场-产业格局

  • 概述
  • 内皮功能障碍市场的成长策略
  • 无机成长策略
    • 概述
  • 有机成长策略
    • 概述

第 12 章：公司简介

  • ZOLL Medical Corp
  • Lawrence Berkeley National Laboratory
  • Endothelix Inc
  • Perimed AB
  • SMART Medical Ltd
  • Everist Health Inc
  • Medizinische Messtechnik GmbH

第 13 章：附录

  • 关于 Insight Partners
  • 专业术语
Product Code: BMIRE00029161

The North America endothelial dysfunction market is expected to grow from US$ 951.83 million in 2022 to US$ 1,247.30 million by 2028. It is estimated to grow at a CAGR of 4.6% from 2022 to 2028.

Increasing Incidences of Cardiovascular Diseases Fuels North America Endothelial Dysfunction Market

According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are among the leading causes of death worldwide, and ~30 million people experience a stroke each year. CVDs include cerebrovascular disease, coronary heart disease, rheumatic heart disease, and coronary artery disease (CAD). CAD is the most common disease among all cardiovascular diseases, and it is characterized by the accumulation of lipids and immune cells in the subendothelial space of the coronary arteries or atherosclerosis. It involves the inflammatory response of the vascular endothelium. CAD is characterized by ischemia, hypoxia, or necrosis of the myocardium resulting from narrowing, spasm, or obstruction of the coronary artery lumen by atherosclerosis. It has become the leading cause of death worldwide. According to the Centers for Disease Control and Prevention (CDC), over 60 million women (44%) in the US suffer from some form of heart disease. Heart disease is the leading cause of death among women in the US and can affect women of any age. In 2021, it caused 310,661 deaths among women, i.e., nearly one in five female deaths.

According to the American Heart Association, almost half of all adults in the US suffer from a type of CVD. Over 130 million people, i.e., 45.1% of the US population, are projected to suffer from a type of CVD by 2035. Therefore, the high prevalence of cardiovascular diseases due to endothelial dysfunction drives the market.

North America Endothelial Dysfunction Market Overview

The North American endothelial dysfunction market is analyzed on the basis of three major countries: the US, Canada, and Mexico. The market expansion in the region can be attributed to an increase in the incidence of cardiac diseases and rising investments in cardiology informatics. The US holds the largest size of the endothelial dysfunction market in North America owing to factors such as the increasing burden of CAD, established healthcare infrastructure, and R&D activities undertaken to develop advanced endothelial dysfunction drugs and devices.

North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

North America Endothelial Dysfunction Market Segmentation

The North America endothelial dysfunction market is segmented into cause, test type, end user, and country.

Based on cause, the North America endothelial dysfunction market is segmented into hypertension, hypercholesterolaemia, obesity, diabetes, behcet's disease, and others. The hypertension segment registered the largest North America endothelial dysfunction market share in 2022.

Based on test type, the North America endothelial dysfunction market is segmented into invasive test and non-invasive test. The invasive test segment held a larger North America endothelial dysfunction market share in 2022. The non-invasive test segment is further subsegmented into flow mediated dilatory, peripheral arterial tonometry (PAT), venous occlusion pletismography, circulating markers, and others.

Based on end user, the North America endothelial dysfunction market has been categorized into hospitals, diagnostic centers, clinics, and others. The hospitals segment held the largest North America endothelial dysfunction market share in 2022.

Based on country, the North America endothelial dysfunction market is segmented into the US, Canada, and Mexico. The US dominated the North America endothelial dysfunction market in 2022.

ZOLL Medical Corp, Lawrence Berkeley National Laboratory, Endothelix Inc, Perimed AB, SMART Medical Ltd, Everist Health Inc, and Medizinische Messtechnik GmbH are some of the leading companies operating in the endothelial dysfunction market in the region.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America endothelial dysfunction market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the North America endothelial dysfunction market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the endothelial dysfunction market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 North America Endothelial Dysfunction Market - by Cause
    • 1.3.2 North America Endothelial Dysfunction Market - by Test Type
    • 1.3.3 North America Endothelial Dysfunction Market - by End User
    • 1.3.4 North America Endothelial Dysfunction Market - by Country

2. North America Endothelial Dysfunction Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Endothelial Dysfunction Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
  • 4.3 Expert Opinion

5. North America Endothelial Dysfunction Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Incidences of Cardiovascular Diseases
    • 5.1.2 Rising Incidences of High Cholesterol, Diabetes And Obesity
  • 5.2 Market Restraints
    • 5.2.1 Disadvantages Associated with the Techniques for Screening of Endothelial Dysfunction
  • 5.3 Market Opportunities
    • 5.3.1 Rising Usage of Novel Biomarkers and Therapeutic Strategies
  • 5.4 Future Trends
    • 5.4.1 Use of Noninvasive Methods to Assess Endothelial Dysfunction
  • 5.5 Impact Analysis

6. Endothelial Dysfunction Market - North America Analysis

  • 6.1 North America Endothelial Dysfunction Market Revenue Forecast and Analysis

7. North America Endothelial Dysfunction Market Analysis - by Cause

  • 7.1 Overview
  • 7.2 North America Endothelial Dysfunction Market, By Cause, 2022 & 2028 (%)
  • 7.3 Hypertension
    • 7.3.1 Overview
    • 7.3.2 Hypertension: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Diabetes
    • 7.4.1 Overview
    • 7.4.2 Diabetes: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Hypercholestrolaemia
    • 7.5.1 Overview
    • 7.5.2 Hypercholestrolaemia: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.6 Behcet's Disease
    • 7.6.1 Overview
    • 7.6.2 Behcet's Disease: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.7 Obesity
    • 7.7.1 Overview
    • 7.7.2 Obesity: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.8 Others
    • 7.8.1 Overview
    • 7.8.2 Others: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

8. North America Endothelial Dysfunction Market Analysis - by Test Type

  • 8.1 Overview
  • 8.2 North America Endothelial Dysfunction Market, By Test Type, 2022 & 2028 (%)
  • 8.3 Invasive Tests
    • 8.3.1 Overview
    • 8.3.2 Invasive Tests: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Non-Invasive Tests
    • 8.4.1 Overview
    • 8.4.2 Non-Invasive Tests: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.3 Flow Mediated Dilatory
      • 8.4.3.1 Overview
      • 8.4.3.2 Flow Mediated Dilatory: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.4 Venous Occlusion Plethysmography
      • 8.4.4.1 Overview
      • 8.4.4.2 Venous Occlusion Plethysmography: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.5 Peripheral Arterial Tonometry (PAT)
      • 8.4.5.1 Overview
      • 8.4.5.2 Peripheral Arterial Tonometry (PAT): North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.6 Circulating Markers
      • 8.4.6.1 Overview
      • 8.4.6.2 Circulating Markers: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.7 Others
      • 8.4.7.1 Overview
      • 8.4.7.2 Others: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

9. North America Endothelial Dysfunction Market Analysis - by End User

  • 9.1 Overview
  • 9.2 North America Endothelial Dysfunction Market, By End User, 2022 & 2028 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Diagnostics Centers
    • 9.4.1 Overview
    • 9.4.2 Diagnostics Centers: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Clinics
    • 9.5.1 Overview
    • 9.5.2 Clinics: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

10. North America Endothelial Dysfunction Market - Revenue and Forecast to 2028 - Country Analysis

  • 10.1 North America: Endothelial Dysfunction Market
    • 10.1.1 Overview
      • 10.1.1.1 US: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 US: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.3 US: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.1.1.4 US: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.1.1.1.4.1 US: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.1.5 US: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.1.1.2 Canada: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Canada: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.3 Canada: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.1.2.4 Canada: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.1.1.2.4.1 Canada: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.2.5 Canada: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.1.1.3 Mexico: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 Mexico: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.3 Mexico: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.1.3.4 Mexico: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.1.1.3.4.1 Mexico: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.3.5 Mexico: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)

11. North America Endothelial Dysfunction Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Endothelial Dysfunction Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 ZOLL Medical Corp
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Lawrence Berkeley National Laboratory
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Endothelix Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Perimed AB
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6
    • 12.4.7 Key Developments
  • 12.5 SMART Medical Ltd
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Everist Health Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Medizinische Messtechnik GmbH
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Techniques Used in to Assess Endothelial Function
  • Table 2. Novel Soluble and Cell Component Biomarkers of Endothelia Dysfunction in Cardiovascular Diseases
  • Table 3. US Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. US Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. US Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. US Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. Canada Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. Canada Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. Canada Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Canada Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Mexico Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Mexico Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Mexico Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Mexico Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Recent Inorganic Growth Strategies in the Endothelial Dysfunction Market
  • Table 16. Recent Organic Growth Strategies in the Endothelial Dysfunction Market
  • Table 17. Glossary of Terms, Endothelial dysfunction market

List Of Figures

  • Figure 1. North America Endothelial Dysfunction Market Segmentation
  • Figure 2. North America Endothelial Dysfunction Market, by Country
  • Figure 3. North America Endothelial Dysfunction Market Overview
  • Figure 4. Hypertension Account for Largest Share of Cause Segment in North America Endothelial Dysfunction Market
  • Figure 5. The US Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. North America: PEST Analysis
  • Figure 7. Expert Opinion
  • Figure 8. North America Endothelial Dysfunction Market: Impact Analysis of Drivers and Restraints
  • Figure 9. North America Endothelial Dysfunction Market - Revenue Forecast and Analysis - 2020-2028
  • Figure 10. North America Endothelial Dysfunction Market, by Cause, 2022 & 2028 (%)
  • Figure 11. Hypertension: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. Diabetes: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Hypercholestrolaemia: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. Behcet's disease: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 15. Obesity: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Others: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. North America Endothelial Dysfunction Market, by Test Type, 2022 & 2028 (%)
  • Figure 18. Invasive Tests: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 19. Non-Invasive Tests: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Flow Mediated Dilatory: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Venous Occlusion Plethysmography: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Peripheral Arterial Tonometry (PAT): North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Circulating Markers: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Others: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. North America Endothelial Dysfunction Market, by End User, 2022 & 2028 (%)
  • Figure 26. Hospitals and Clinics: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Diagnostics Centers: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Clinics: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Others: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. North America: Endothelial Dysfunction Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 31. North America: Endothelial Dysfunction Market, by Country, 2022 & 2028 (%)
  • Figure 32. US: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 33. Canada: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 34. Mexico: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 35. Growth Strategies in the Endothelial Dysfunction Market